Pathology and Treatments of Amyotrophic Lateral Sclerosis (ALS)

Dear Colleagues,

This Special Issue focuses on amyotrophic lateral sclerosis (ALS), a serious neuromuscular disease that affects nerve cells in the brain and the spinal cord, leading to muscle weakness, disability, and death. This Special Issue aims to gather research on the latest findings in the pathology of ALS, including studies on how the disease develops, its effects on the body, and the molecular mechanisms of disease pathogenesis. It also seeks to highlight new and existing treatments that can help manage symptoms and improve quality of life for patients.

Researchers and experts are invited to submit papers that explore various aspects of ALS, including its biological mechanisms, risk factors, diagnostic tools, and innovative treatment methods. We welcome studies that examine basic laboratory findings and reviews that summarize current knowledge in the field. The goal is to create a comprehensive collection of work that enhances our understanding and guides future research and treatment strategies for ALS.

All submissions should adhere to Cells’ guidelines and should be submitted by the deadline. We look forward to your contributions to this important field of study.

Prof. Dr. Laxman Gangwani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.